These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 21944886)

  • 1. Transfer of the amyloid β and/or of β-amyloid precursor protein of the fetus with trisomy 21 to the maternal blood stream and its possible contribution to the pathogenesis of the maternal Alzheimer's Disease.
    Mohamad López H
    Med Hypotheses; 2011 Dec; 77(6):1058-61. PubMed ID: 21944886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-amyloid controls altered Reelin expression and processing in Alzheimer's disease.
    Botella-López A; Cuchillo-Ibáñez I; Cotrufo T; Mok SS; Li QX; Barquero MS; Dierssen M; Soriano E; Sáez-Valero J
    Neurobiol Dis; 2010 Mar; 37(3):682-91. PubMed ID: 20025970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation.
    Lemere CA; Blusztajn JK; Yamaguchi H; Wisniewski T; Saido TC; Selkoe DJ
    Neurobiol Dis; 1996 Feb; 3(1):16-32. PubMed ID: 9173910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BACE2, as a novel APP theta-secretase, is not responsible for the pathogenesis of Alzheimer's disease in Down syndrome.
    Sun X; He G; Song W
    FASEB J; 2006 Jul; 20(9):1369-76. PubMed ID: 16816112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting increased levels of APP in Down syndrome: Posiphen-mediated reductions in APP and its products reverse endosomal phenotypes in the Ts65Dn mouse model.
    Chen XQ; Salehi A; Pearn ML; Overk C; Nguyen PD; Kleschevnikov AM; Maccecchini M; Mobley WC
    Alzheimers Dement; 2021 Feb; 17(2):271-292. PubMed ID: 32975365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Biological characteristics of amyloid precursor protein and Alzheimer's disease].
    Fukatsu R; Tsuzuki K; Takamaru Y; Hayashi Y; Sasaki N; Yoshida T; Midorikawa Y; Fujii N; Takahata N
    Rinsho Byori; 1996 Mar; 44(3):213-24. PubMed ID: 8857163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased amyloid beta protein levels in children and adolescents with Down syndrome.
    Mehta PD; Capone G; Jewell A; Freedland RL
    J Neurol Sci; 2007 Mar; 254(1-2):22-7. PubMed ID: 17275850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Elucidating Pathogenic Mechanisms of Early-onset Alzheimer's Disease in Down Syndrome Patients].
    Asai M; Kawakubo T; Mori R; Iwata N
    Yakugaku Zasshi; 2017; 137(7):801-805. PubMed ID: 28674290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's disease and down syndrome: from meiosis to dementia.
    Petronis A
    Exp Neurol; 1999 Aug; 158(2):403-13. PubMed ID: 10415146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amino-terminal modification and tyrosine phosphorylation of [corrected] carboxy-terminal fragments of the amyloid precursor protein in Alzheimer's disease and Down's syndrome brain.
    Russo C; Salis S; Dolcini V; Venezia V; Song XH; Teller JK; Schettini G
    Neurobiol Dis; 2001 Feb; 8(1):173-80. PubMed ID: 11162251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracellular Abeta42 activates p53 promoter: a pathway to neurodegeneration in Alzheimer's disease.
    Ohyagi Y; Asahara H; Chui DH; Tsuruta Y; Sakae N; Miyoshi K; Yamada T; Kikuchi H; Taniwaki T; Murai H; Ikezoe K; Furuya H; Kawarabayashi T; Shoji M; Checler F; Iwaki T; Makifuchi T; Takeda K; Kira J; Tabira T
    FASEB J; 2005 Feb; 19(2):255-7. PubMed ID: 15548589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual-specificity tyrosine(Y)-phosphorylation regulated kinase 1A-mediated phosphorylation of amyloid precursor protein: evidence for a functional link between Down syndrome and Alzheimer's disease.
    Ryoo SR; Cho HJ; Lee HW; Jeong HK; Radnaabazar C; Kim YS; Kim MJ; Son MY; Seo H; Chung SH; Song WJ
    J Neurochem; 2008 Mar; 104(5):1333-44. PubMed ID: 18005339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The production ratios of AICDε51 and Aβ42 by intramembrane proteolysis of βAPP do not always change in parallel.
    Mori K; Okochi M; Tagami S; Nakayama T; Yanagida K; Kodama TS; Tatsumi S; Fujii K; Tanimukai H; Hashimoto R; Morihara T; Tanaka T; Kudo T; Funamoto S; Ihara Y; Takeda M
    Psychogeriatrics; 2010 Sep; 10(3):117-23. PubMed ID: 20860566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of risk factors of Alzheimer's disease in the Down syndrome.
    Folin M; Baiguera S; Conconi MT; Pati T; Grandi C; Parnigotto PP; Nussdorfer GG
    Int J Mol Med; 2003 Feb; 11(2):267-70. PubMed ID: 12525890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene expression profiling in the adult Down syndrome brain.
    Lockstone HE; Harris LW; Swatton JE; Wayland MT; Holland AJ; Bahn S
    Genomics; 2007 Dec; 90(6):647-60. PubMed ID: 17950572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recent advances in Alzheimer's disease research--amyloid precursor protein trafficking, processing, and mutations in Alzheimer's disease linked genes].
    Fukatsu R; Tsuzuki K; Hayashi Y; Takamaru Y; Sasaki N; Yoshida T; Hatakeyama Y; Fuji N; Takahata N
    Hokkaido Igaku Zasshi; 1997 Jan; 72(1):3-11. PubMed ID: 9086357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alzheimer's disease and the amyloid β-protein.
    Walsh DM; Teplow DB
    Prog Mol Biol Transl Sci; 2012; 107():101-24. PubMed ID: 22482449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Advances in molecular biology and clinical study of amyloid precursor protein for Alzheimer's disease].
    Xu BG; Wu X
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Apr; 26(2):201-9. PubMed ID: 15171563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen, beta-amyloid metabolism/trafficking, and Alzheimer's disease.
    Xu H; Wang R; Zhang YW; Zhang X
    Ann N Y Acad Sci; 2006 Nov; 1089():324-42. PubMed ID: 17261779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyloid beta protein (Abeta) deposition in chromosome 14-linked Alzheimer's disease: predominance of Abeta42(43).
    Mann DM; Iwatsubo T; Cairns NJ; Lantos PL; Nochlin D; Sumi SM; Bird TD; Poorkaj P; Hardy J; Hutton M; Prihar G; Crook R; Rossor MN; Haltia M
    Ann Neurol; 1996 Aug; 40(2):149-56. PubMed ID: 8773595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.